Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.
Meattini I, Desideri I, Di Cataldo V, Francolini G, De Luca Cardillo C, Scotti V, Loi M, Detti B, Mangoni M, Agresti B, Baldazzi V, Greto D, Casella D, Bernini M, Sanchez LJ, Orzalesi L, Nori J, Fambrini M, Bianchi S, Livi L.
Meattini I, et al. Among authors: orzalesi l.
Future Oncol. 2016 May;12(9):1117-24. doi: 10.2217/fon-2015-0059. Epub 2016 Mar 9.
Future Oncol. 2016.
PMID: 26956105